An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety

作者：Linlin Shi, Xinkai Wu, Tongyu Li, Yuan Wu, Liwei Song, Wei Zhang, Luxi Yin, Yuhui Wu, Weidong Han, Yunhai Yang · 发表于：Nanoscale Advances · 年份：2021 · DOI：10.1039/d1na00838b · 被引用次数：25 · 研究领域：Nanoparticle-Based Drug Delivery、RNA Interference and Gene Delivery、Nanoplatforms for cancer theranostics

, alleviated bloody diarrhea and liver damage) in multiple mice models. These results may be ascribed to extended systemic circulation and preferential tumor accumulation of our nanodrugs. Hence, our findings demonstrate that rational engineering of therapeutic nanomedicine is a promising approach for effective and safe delivery of antitumor chemotherapeutics, especially to rescue drug candidates that have failed in clinical trials owing to poor PK properties or severe toxicity in patients.